Guerciolini R, Giordano G, Aversa F, Del Favero A
Acta Haematol. 1985;73(4):232-4. doi: 10.1159/000206335.
Although ticlopidine has proven anti-aggregant properties, complications due to side-effects, particularly to the haemopoietic system, have been noted since it was recently launched on the market. We here report a case of bicytopenia (anaemia and granulocytopenia) associated with ticlopidine treatment.
尽管噻氯匹定已被证实具有抗血小板聚集特性，但自从它最近投放市场以来，已注意到其副作用引起的并发症，尤其是对造血系统的副作用。我们在此报告一例与噻氯匹定治疗相关的双血细胞减少症（贫血和粒细胞减少症）病例。
